|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
JPRN |
|
Last refreshed on:
|
17 October 2023 |
|
Main ID: |
JPRN-UMIN000036332 |
|
Date of registration:
|
28/03/2019 |
|
Prospective Registration:
|
Yes |
|
Primary sponsor: |
|
|
Public title:
|
Ascorbic acid treatment for Charcot-Marie-Tooth disease type 1A
|
|
Scientific title:
|
Ascorbic acid treatment for Charcot-Marie-Tooth disease type 1A - Ascorbic acid treatment for CMT1A |
|
Date of first enrolment:
|
2019/06/15 |
|
Target sample size:
|
10 |
|
Recruitment status: |
Pending |
|
URL:
|
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000041396 |
|
Study type:
|
Interventional |
|
Study design:
|
Single arm Non-randomized
|
|
Phase:
|
Phase I
|
|
|
Countries of recruitment
|
|
Japan
| | | | | | | |
|
Contacts
|
|
Name:
|
Reiko
Aoyagi |
|
Address:
|
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, Japan
260-8670
Japan |
|
Telephone:
|
043-222-7171 |
|
Email:
|
prc-jim@chiba-u.jp |
|
Affiliation:
|
Chiba University Hospital Department of Clinical Investigation |
|
|
Name:
|
Katsunori
Fujii |
|
Address:
|
1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba, Japan
Japan |
|
Telephone:
|
043-226-2144 |
|
Email:
|
kfujii@faculty.chiba-u.jp |
|
Affiliation:
|
Chiba University Graduate School of Medicine Department of Pediatrics |
| |
|
Key inclusion & exclusion criteria
|
Inclusion criteria:
Exclusion criteria: 1. Unsuitable patient judged by the medical doctor
Age minimum:
1years-old
Age maximum:
Not applicable
Gender:
Male and Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Charcot-Marie-Tooth diease type 1A
|
|
Intervention(s)
|
|
Ascorbic acid treatment: 20mg/kg/day, dayly
|
|
Primary Outcome(s)
|
|
Charcot-Marie-Tooth disease neurological score will be used for primary outcome every 24 weeks after ascorbic acid treatment
|
|
Secondary Outcome(s)
|
|
Electrophysiological examination including latency, conduction velocity, temporal dispersion and compund muscle action potential.
|
|
Source(s) of Monetary Support
|
|
Chiba University
|
|
Ethics review
|
Status: YES
Approval date:
Contact:
prc-jim@chiba-u.jp
Chiba University
043-222-7171
prc-jim@chiba-u.jp
|
|
Results
|
|
Results available:
|
Yes |
|
Date Posted:
|
|
|
Date Completed:
|
14/06/2034 |
|
URL:
|
|
|
|